Passage Bio appoints William Chou as CEO, replacing interim CEO Chip Cale

Passage BIO, Inc.

William Chou appointed CEO and director effective October 10, 2022.
Edgar B. Cale resigned as interim CEO; continues as General Counsel and Corporate Secretary.
Dr. Chou receives $580k base salary, 55% target bonus, and $200k sign-on bonus with clawback.
Granted option to purchase 885,000 shares vesting over 4 years.
Severance includes 12 months base salary plus bonus on termination without cause.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change (interim)

Edgar B. (Chip) Cale

Interim Chief Executive Officer

PASG · Passage BIO, Inc.

Effective: 2022-10-10
Successor: William Chou
Filed: October 11, 2022, 7:59 PM ET

Edgar B. (Chip) Cale resigned from his position as the Company’s Interim Chief Executive Officer.

Appointed

William Chou

Chief Executive Officer and Director

PASG · Passage BIO, Inc.

Effective: 2022-10-10
Filed: October 11, 2022, 7:59 PM ET

the board of directors (the “Board”) of Passage Bio, Inc. (the “Company”) appointed William Chou, M.D., age 50, as (i) Chief Executive Officer and (ii) a member of the Board

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Edgar B. (Chip) Cale resigned as Interim Chief Executive Officer at Passage BIO, Inc..

Action: resigned
Role: Interim Chief Executive Officer

Exact text from the filing

Edgar B. (Chip) Cale resigned from his position as the Company’s Interim Chief Executive Officer.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

William Chou was appointed as Chief Executive Officer and Director at Passage BIO, Inc..

Action: appointed
Role: Chief Executive Officer and Director

Exact text from the filing

the board of directors (the “Board”) of Passage Bio, Inc. (the “Company”) appointed William Chou, M.D., age 50, as (i) Chief Executive Officer and (ii) a member of the Board

View on SEC.gov

Passage BIO, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-22-107408

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.